News Archive

Masonic Cancer Center Articles

Pratt new

Masonic Cancer Center announces the appointment of Dr. Rebekah Pratt as Co-Associate Director of Community Outreach and Engagement

December 22, 2021
Rebekah Pratt, PhD, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Lange

Masonic Cancer Center announces the appointment of Dr. Carol Lange to Associate Director

December 20, 2021
Carol Lange, PhD, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Schwertfeger

Masonic Cancer Center announces appointment of Dr. Kaylee Schwertfeger to a leadership role

December 20, 2021
Kaylee Schwertfeger, PhD, Professor in the Medical School’s Department of Laboratory Medicine and Pathology, has been appointed as the Co-Leader of the Cellular Mechanisms program at the Twin Cities’ only National Cancer Institute (NCI)…
Geller

Masonic Cancer Center announces the appointment of Dr. Melissa Geller to Associate Director

December 15, 2021
Melissa Geller, MD, MS, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Lung Cancer

Lung cancer awareness with the U of M: Smoking, radon, and cancer treatment and prevention

November 11, 2021
MINNEAPOLIS/ST. PAUL (11/11/2021) — Lung Cancer Awareness Month is recognized every year during the month of November. The Masonic Cancer Center and University of Minnesota, including the Medical School and the School of Public Health,…
10kfs

10,000 Families Study Receives NCI Grant to Study Environmental Exposures and Cancer Risk

October 12, 2021
MINNEAPOLIS, MN- October 12, 2021 - A University of Minnesota-based team was recently awarded a UG3 grant from the National Cancer Institute (NCI): “
MCC Logo

University of Minnesota Research Team Awarded R01 Grant from the NCI to Study Head and Neck Squamous Cell Carcinoma

September 27, 2021
MINNEAPOLIS, MN- September 27, 2021 - Awarded from the National Cancer Institute (NCI), a study based at the University of Minnesota will develop a profile analysis of oral cell DNA that may predict head and neck squamous cell carcinoma (…
Masonic Cancer Center Logo

Masonic Cancer Center invited to participate in a ASCO/ACCC diversity-based pilot project  

September 20, 2021
The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) recently announced that the Masonic Cancer Center, University of Minnesota, was chosen as one of 75 research sites to participate in a…
Spector

University of Minnesota Professor Awarded R01 Grant from the NCI to Identify Prenatal Origin of Leukemia

September 7, 2021
MINNEAPOLIS, MN - A study, based at the University of Minnesota, that will examine the prenatal origins of pediatric leukemia, has been awarded a prestigious R01 grant from the National Cancer Institute (NCI).
Antonarakis

Dr. Emmanuel Antonarakis named Masonic Cancer Center Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division

August 31, 2021
August 31, 2021 - Emmanuel S. Antonarakis, MD, has joined the faculty at the University of Minnesota Medical School where he has been appointed the Associate Director for Translational Research at the Masonic Cancer Center. Dr.